Advanced Proteome Therapeutics Corporation Obtains Option to License Antibody Candidates and Collaborates With CCAB to Jointly Fund Research
October 19, 2016 08:00 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - October 19, 2016) - Advanced Proteome Therapeutics Corporation (APC) (TSX VENTURE: APC) (FRANKFURT: 0E8), a biopharmaceutical company dedicated to creating, developing,...
Advanced Proteome Therapeutics Retains Virtus Advisory Group to Provide Corporate Communication Services
October 07, 2016 17:14 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - October 07, 2016) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that it has retained...
Advanced Proteome Therapeutics Corporation Formulates Strategic Plan Featuring Novel Antibody Program
July 18, 2016 09:00 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - July 18, 2016) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) announces plans bearing on its site-specific...
Advanced Proteome Therapeutics Corporation and Wilex Subsidiary Heidelberg Pharma Collaborate to Create Improved Cancer Therapeutics
June 14, 2016 09:00 ET
|
Advanced Proteome Therapeutics Corporation;WILEX AG
MUNICH, GERMANY and VANCOUVER, BC--(Marketwired - June 14, 2016) - WILEX AG (ISIN DE000A11QVV0 / WL6 / FSE) and Advanced Proteome Therapeutics Corporation, Vancouver, Canada (TSX VENTURE: APC)...
Advanced Proteome Closes Private Placement
May 19, 2016 18:26 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - May 19, 2016) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Advanced Proteome Therapeutics...
Advanced Proteome Announces Private Placement
April 18, 2016 09:30 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC --(Marketwired - April 18, 2016) - Advanced Proteome Therapeutics Corporation (TSX VENTURE: APC)(FRANKFURT: 0E8)
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR...
Advanced Proteome Therapeutics Corporation Embarks Upon a Major Antibody Initiative
April 15, 2016 09:15 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - April 15, 2016) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) announces that APC has invented a novel...
Advanced Proteome Therapeutics (APC) to Attend BIO-Europe Spring 2016 Partnering Conference
March 24, 2016 09:30 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - March 24, 2016) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) announces that APC will be attending the...
Advanced Proteome Therapeutics Corporation Attending JP Morgan Healthcare Conference Week January 10-14th, 2016
January 04, 2016 09:30 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - January 04, 2016) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) will be attending the Biotech Showcase...
Advanced Proteome Therapeutics Updates Study of APC 101
December 04, 2015 19:43 ET
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - December 04, 2015) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is following up on its news release of April...